1. Home
  2. JANX vs SCHL Comparison

JANX vs SCHL Comparison

Compare JANX & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$15.18

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Logo Scholastic Corporation

SCHL

Scholastic Corporation

HOLD

Current Price

$39.75

Market Cap

842.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
JANX
SCHL
Founded
2017
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
790.3M
842.4M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
JANX
SCHL
Price
$15.18
$39.75
Analyst Decision
Buy
Hold
Analyst Count
12
1
Target Price
$50.09
$40.00
AVG Volume (30 Days)
929.9K
662.1K
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
2.00%
EPS Growth
N/A
N/A
EPS
N/A
1.87
Revenue
$10,000,000.00
$1,487,100,000.00
Revenue This Year
N/A
$1.75
Revenue Next Year
N/A
$4.23
P/E Ratio
N/A
$21.13
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$16.03
52 Week High
$35.34
$40.15

Technical Indicators

Market Signals
Indicator
JANX
SCHL
Relative Strength Index (RSI) 61.72 67.58
Support Level $13.10 $27.50
Resistance Level $15.49 $39.65
Average True Range (ATR) 0.57 0.59
MACD 0.09 -0.08
Stochastic Oscillator 86.29 68.93

Price Performance

Historical Comparison
JANX
SCHL

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: